This site is intended for healthcare professionals only
LoginRegister
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges CentreInclude intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre
Two doses of Jynneos vaccine significantly effective in treating monkeypoxTwo doses of Jynneos vaccine significantly effective in treating monkeypox
1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt
Takeda Dengue Tetravalent Vaccine QDENGA gets European Commission nodTakeda Dengue Tetravalent Vaccine QDENGA gets European Commission nod
FDA authorizes availability of bivalent COVID-19 vaccines for children six months to 4 years of ageFDA authorizes availability of bivalent COVID-19 vaccines for children six months to 4 years of age
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineDCGI allows Serum Institute to export Ebola vaccine to Uganda
Pfizer secures USFDA priority review for RSV vaccine for older adultsPfizer secures USFDA priority review for RSV vaccine for older adults
India to make significant investment in RnD to develop roadmap for design, delivery of vaccine development for future pandemic: Dr Jitendra SinghIndia to make significant investment in RnD to develop roadmap for design, delivery of vaccine...
Novavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescentsNovavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescents
Holding methotrexate for one week after flu vaccine as effective as two-week hold among RA patientsHolding methotrexate for one week after flu vaccine as effective as two-week hold among RA patients
Britain health regulator authorizes Pfizer-BioNTech COVID vaccine for children aged 6 months to 4 years oldBritain health regulator authorizes Pfizer-BioNTech COVID vaccine for children aged 6 months to 4...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 yearsPfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19...
X